Endologix is a pioneering brand committed to improving the lives of patients with vascular disease. With a focus on disruptive innovation and guided by data, Endologix addresses persistent unmet needs in patients with vascular disease. Their portfolio includes transformative therapies such as the EVAR Portfolio and the DETOUR System.

As the first to introduce virtual reality (VR) procedural training for EVAR, Endologix empowers physicians with immersive training programs that offer unique benefits. The brand's unwavering commitment to the highest quality clinical evidence ensures that they take measured and responsible approaches to focused innovation. By appointing a vascular surgeon as President and CEO, Endologix prioritizes the needs of vascular clinicians and patients.

With Endologix, healthcare professionals and patients alike can embrace the evidence and confidently redefine what is possible in the treatment of vascular disease